Insights into cGMP signalling derived from cGMP kinase knockout mice

Area of Science:

• Physiology
• Molecular Biology
• Pharmacology

Background:

• Cyclic guanosine monophosphate (cGMP) signaling is crucial in physiological processes across various organs, including the vasculature, gastrointestinal tract, and nervous system.
• cGMP-elevating drugs, like glyceryl trinitrate, are vital in treating cardiovascular diseases.
• Nitric oxide (NO) and natriuretic peptides induce cGMP synthesis by stimulating guanylyl cyclases.

Purpose of the Study:

• To elucidate the distinct physiological roles of cGMP-dependent protein kinase type I (cGKI) and type II (cGKII) in different organs.
• To utilize genetically modified mouse models (total and tissue-specific knockout mice) to investigate cGMP-mediated signaling pathways.

Main Methods:

• Generation and analysis of total and tissue-specific cGKI- and cGKII-deficient mice.
• Phenotypic characterization of these mutant mice to determine functional significance in various physiological systems.

Main Results:

• cGKI plays a significant role in regulating the cardiovascular system, gastrointestinal tract, learning and memory (hippocampus and cerebellum), and pain perception.
• cGKII is implicated in intestinal water secretion, bone growth, and circadian rhythmicity.
• The developed cGK mutant mice serve as valuable tools for studying cGMP signaling.

Conclusions:

• cGKI and cGKII exhibit distinct and critical functions in diverse physiological processes.
• Understanding these specific roles provides insights into cGMP-mediated signaling in both health and disease.
• Genetically engineered mouse models are essential for dissecting complex signaling pathways.